These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7845151)

  • 1. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
    Benhamou Y; Dohin E; Lunel-Fabiani F; Poynard T; Huraux JM; Katlama C; Opolon P; Gentilini M
    Lancet; 1995 Feb; 345(8946):396-7. PubMed ID: 7845151
    [No Abstract]   [Full Text] [Related]  

  • 2. Lamivudine useful against hepatitis B-HIV co-infection.
    Prescott LM
    J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):34. PubMed ID: 11362610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral dynamics in hepatitis B virus infection.
    Nowak MA; Bonhoeffer S; Hill AM; Boehme R; Thomas HC; McDade H
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4398-402. PubMed ID: 8633078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.
    Benhamou Y; Katlama C; Lunel F; Coutellier A; Dohin E; Hamm N; Tubiana R; Herson S; Poynard T; Opolon P
    Ann Intern Med; 1996 Nov; 125(9):705-12. PubMed ID: 8929003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B reactivation after lamivudine.
    Honkoop P; de Man RA; Heijtink RA; Schalm SW
    Lancet; 1995 Oct; 346(8983):1156-7. PubMed ID: 7475613
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunodeficiency and new treatment for HBV.
    Benhamou Y
    Nurs Stand; 1995 Mar 1-7; 9(23):14. PubMed ID: 7703142
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.
    Thabut D; Thibault V; Benhamou Y; Bernard B; Aubron-Olivier C; Poynard T; Di Martino V
    AIDS; 2001 Dec; 15(18):2463-4. PubMed ID: 11774835
    [No Abstract]   [Full Text] [Related]  

  • 8. Lamivudine: a magic bullet for chronic hepatitis B?
    Grimm I
    Gastroenterology; 1996 Jul; 111(1):262-4. PubMed ID: 8698214
    [No Abstract]   [Full Text] [Related]  

  • 9. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
    Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
    J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro evaluation of combination therapies against hepatitis B virus replication.
    Korba BE
    Antiviral Res; 1996 Jan; 29(1):49-51. PubMed ID: 8721544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHS recommends preventive drugs for HIV exposures.
    OR Manager; 1996 Aug; 12(8):1, 6. PubMed ID: 10161372
    [No Abstract]   [Full Text] [Related]  

  • 12. A quarter-century of antiviral therapy.
    Merigan TC
    N Engl J Med; 1995 Dec; 333(25):1704-5. PubMed ID: 7477225
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
    Alvarez-Uria G; Ratcliffe L; Vilar J
    HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lamivudine on the replication of hepatitis B virus in HIV-infected patients depends on the host immune status (CD4 cell count).
    Haverkamp M; Smit M; Weersink A; Boucher CA; Hoepelman AI
    AIDS; 2003 Jul; 17(10):1572-4. PubMed ID: 12824802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.
    Manegold C; Hannoun C; Wywiol A; Dietrich M; Polywka S; Chiwakata CB; Günther S
    Clin Infect Dis; 2001 Jan; 32(1):144-8. PubMed ID: 11118394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes.
    Condreay LD; Condreay JP; Jansen RW; Paff MT; Averett DR
    Antimicrob Agents Chemother; 1996 Feb; 40(2):520-3. PubMed ID: 8834915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine inhibits hepatitis B virus replication in kidney graft recipients.
    Goffin E; Horsmans Y; Cornu C; Squifflet JP; Pirson Y
    Transplantation; 1998 Aug; 66(3):407-9. PubMed ID: 9721816
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advance in clinical studies of the kinetics of hepatitis B virus].
    Tang YT; Cao Q; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):75-7. PubMed ID: 20128981
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy for hepatitis B virus infections: new targets and technical challenges.
    Feld J; Locarnini S
    J Clin Virol; 2002 Dec; 25(3):267-83. PubMed ID: 12423691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.